Norliqva oral solution on a white pharmacy counter beside a glass-door refrigerator; inside it, a bottle labeled Katerzia oral suspension. The refrigerator's display reads 2.8 °C. Pharmacy shelving stands behind.
| Norliqva®1,†(amlodipine) Oral Solution | Katerzia®2,‡(amlodipine) Oral Suspension | |
|---|---|---|
| Alcohol-free | Yes | Yes |
| No shaking | Yes | No |
| No refrigeration | Yes | No |
| Patient copay as low as $0* | Yes | No |
This comparison is based on each product’s Prescribing Information and published copay program terms (11/10/26). This is not intended to imply comparable indications, efficacy, safety, or clinical outcomes. No head-to-head studies have been conducted. See the full Prescribing Information for each product. Report adverse events or medical information requests for other products to their respective manufacturers.
As of 11/10/26, Katerzia provides a copay program with a payment as low as $30.3
*Eligible patients may pay as little as $0 per prescription through the CMP EasyPay Copay Program. Available to commercially insured, commercially uninsured and cash patients. Not valid for patients enrolled in Medicare, Medicaid, TRICARE, VA, or any other state or federally funded healthcare program, or where prohibited by law. Maximum savings of up to $150 off per 1-89-day supply and up to $450 off per 90+ day supply. Patient out-of-pocket cost will vary by insurance plan; patients with high deductibles or non-covered status may pay more than $0. Program is not health insurance, cannot be combined with other offers, and may be modified or discontinued without notice. Full terms and conditions at easypaysavings.com/terms.
†Norliqva® is a registered trademark of CMP Development LLC. © 2026 CMP Pharma, Inc. All rights reserved. Product images not actual size.
‡Katerzia® is a registered trademark of Azurity Pharmaceuticals, Inc. CMP Pharma, Inc. is not affiliated with, sponsored by, or endorsed by Azurity Pharmaceuticals, Inc.
Indication
Norliqva is a calcium channel blocker for the treatment of hypertension in adults and children 6 years of age and older, to lower blood pressure. Norliqva is indicated for the treatment of coronary artery disease: chronic stable angina, vasospastic angina (Prinzmetal’s or variant angina), and angiographically documented coronary artery disease in patients without heart failure or an ejection fraction <40%.
Contraindications
NORLIQVA is contraindicated in patients with sensitivity to amlodipine.
Warnings and Precautions
NORLIQVA may cause the following conditions.
- Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, acute hypotension is unlikely.
- Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of NORLIQVA, particularly in patients with severe obstructive coronary artery disease.
- Titrate slowly in patients with severe hepatic impairment.
Copay support and insurance coverage
Patients may pay as little as $0 with the EasyPay Copay Program*
Not valid for patients enrolled in Medicare, Medicaid, or other government programs. Restrictions apply, see terms.
- More than half of EasyPay redemptions had a $0 out-of-pocket cost3
- 2 out of 3 EasyPay redemptions had an out-of-pocket cost of $30 or less3
Based on EasyPay redemptions, 1/1/26 to 10/26/26. Includes commercially insured, insured-not-covered, and cash-pay claims. Individual out-of-pocket costs vary.
Click below for EasyPay Copay Card information or call 1-844-567-9503
Coverage opportunities with many plans§
- Covered by state Medicaid fee-for-service programs in all 50 states and the District of Columbia‖
- Commercial coverage across many major plans3
§This piece represents coverage as of 10/20/26. Please reach out to the specific insurance carrier in question to determine coverage at the point at which you would like to access coverage. Speak directly to the applicable insurance provider to understand any individual’s specific coverage. Covered products can include considerations such as cost-sharing, prior authorization, or step therapy requirements.
‖Norliqva is covered by state Medicaid fee-for-service programs in all 50 states and the District of Columbia as of 10/20/26, according to MCO HUB. Coverage is not a guarantee of payment. Requirements vary by state and by Medicaid managed care plan and may include prior authorization, step therapy, quantity limits, or preferred drug list restrictions. Coverage is subject to change without notice. Contact the state Medicaid program or managed care plan to verify coverage for an individual patient. The EasyPay Copay Program is not valid for patients enrolled in Medicaid, or any other state or federally funded healthcare program.
-
Dosing information1
1 mg/mL amlodipine concentration
-
Access and cost
Patient copay as low as $0*
Not valid for patients enrolled in Medicare, Medicaid, or other government programs
Insurance coverage options
Proven efficacy and indicated for hypertension in adults and children ≥6 years of age.1 Bioequivalent to amlodipine tablets.6
- Norliqva is also indicated for the treatment of coronary artery disease: chronic stable angina, vasospastic angina (Prinzmetal’s or variant angina), and angiographically documented coronary artery disease in patients without heart failure or an ejection fraction <40%1
Ready to order?
Order Norliqva today. Contact your wholesaler.
- 150-mL bottle
- NDC: 46287-037-01
Ready to meet with a representative?
Fill out this form to be contacted by a CMP representative.